Pharmacy Times
SEPTEMBER 11, 2024
The DEA will have a hearing in December 2024 regarding the potential reclassification of cannabis to Schedule III, which could significantly impact the regulatory environment for pharmacies and their involvement in the cannabis market.
Drug Topics
SEPTEMBER 9, 2024
LEO Pharma presented data from 2 of the largest multinational real-world studies on the prevalence, severity and treatment of chronic hand eczema at the European Society of Contact Dermatitis congress.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
PharmaVoice
SEPTEMBER 13, 2024
Three of the largest fundraising rounds in 2024 show where investors are willing to place their bets in biotech.
Fuld
SEPTEMBER 11, 2024
Competitive intelligence and scenario planning tools help companies stay ahead of market trends and outsmart the competition In today’s volatile, uncertain, complex, and ambiguous (VUCA) world, your business needs more than just reactive strategies—it needs a proactive approach. Fuld’s Scenario Planning Toolkit helps executives to anticipate external threats and seize opportunities before they materialize and is your go-to resource for staying ahead of the competition.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Pharmacy Times
SEPTEMBER 13, 2024
AI is significantly enhancing the efficiency of identifying and enrolling patients.
Drug Topics
SEPTEMBER 13, 2024
Gilead said data from the study will support global regulatory filings that the company plans to begin by the end of the year.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
Pharmacy Is Right For Me
SEPTEMBER 13, 2024
Written by: Toni Mikhael, PharmD, Touro College of Pharmacy Class of 2024. PGY-1 Pharmacy Resident, WellSpan Ephrata Community Hospital, Ephrata, PA Edited by: Anastasiya Shor, PharmD, BCPS Pharmacy school is a challenging but rewarding journey. As students embark on this demanding path, it becomes crucial to equip themselves with a toolkit for success.
Pharmacy Times
SEPTEMBER 13, 2024
In the absence of a common treatment for long COVID, researchers from around the world documented the best currently available therapies.
Drug Topics
SEPTEMBER 13, 2024
During an interview, Joseph Shields of TransparencyRx discusses the PBM legislation that is expected to move forward in Congress in the next few months.
PharmaVoice
SEPTEMBER 11, 2024
A handful of potential blockbusters are marching toward FDA review.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
STAT
SEPTEMBER 13, 2024
A close contact of the person in Missouri who had an unexplained H5N1 bird flu infection last month was also sick around the same time, but was not tested for influenza, the Centers for Disease Control and Prevention reported on Friday. The CDC revealed the previously undisclosed information in FluView , its weekly report on influenza activity.
Pharmacy Times
SEPTEMBER 10, 2024
To help with treatment response and compliance as well as optimize treatment, communication between patients and health care providers is necessary.
Drug Topics
SEPTEMBER 11, 2024
The “cuddle hormone” plays a powerful role in human behavior and may be an additional option to treat pain and manage opioid addiction.
PharmaVoice
SEPTEMBER 11, 2024
A broader approach recognizes the challenges disproportionately impacting women and could lead to better outcomes, according to Organon.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
STAT
SEPTEMBER 13, 2024
For more cancer coverage, sign up for STAT’s pop-up newsletter focused on this weekend’s European Society for Medical Oncology conference, one of the biggest oncology meetings of the year. Details here. When Rachel Guberman found out she had brain cancer, she did so much reading and Googling about the disease that she joked she had reached the end of the internet.
Pharmaceutical Technology
SEPTEMBER 13, 2024
Distribution of the self-amplifying mRNA vaccine Kostaive is set to align with a planned October 2024 Covid-19 vaccination campaign.
Drug Topics
SEPTEMBER 13, 2024
Researchers conducted a meta-analysis detailing previous patient outcomes in response to visual art therapy interventions.
PharmaVoice
SEPTEMBER 10, 2024
Quality-adjusted life years are an important tool to frame a drug’s cost effectiveness, but they leave out other determinants of health.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
STAT
SEPTEMBER 12, 2024
Disease investigators have not been able to determine how a person in Missouri with no known exposures to animals or poultry became infected with an H5 bird flu virus, the principal deputy director of the Centers for Disease Control and Prevention said Thursday. But Nirav Shah said the ongoing investigation has turned up no evidence of onward spread of the virus, suggesting this case may turn out to be a one-off infection that defies explanation.
Pharmacy Times
SEPTEMBER 13, 2024
Data show the value of the pharmacist is clear for patients with type 2 diabetes, as their role can have a significant impact on reductions in hemoglobin A1c.
Drug Topics
SEPTEMBER 10, 2024
Researchers explored an alternative pharmacist education intervention as a way of improving pharmacist-patient conversations and decreasing vaccine hesitancy among patients.
PharmaVoice
SEPTEMBER 10, 2024
Over the past 10 years, PD1-blocking medicines have transformed cancer care. But the steady expansion of their use has slowed and, despite much trying, pharmaceutical companies have largely failed to top the drugs’ successes.
STAT
SEPTEMBER 11, 2024
CHICAGO — The last place you might have expected Kevin Hall to make a plea for help was at a conference of scientists who work for global food conglomerates. After all, the government researcher is the leading scientific voice in the United States warning that a steady diet of these engineered products might be a crucial driver of the nation’s epidemic of overeating.
Pharmacy Times
SEPTEMBER 13, 2024
The Hearing Aid Feature can be customized to the user’s needs by amplifying sounds for individuals 18 years or older who have perceived mild to moderate hearing impairments.
Drug Topics
SEPTEMBER 10, 2024
Data from the SELECT clinical trial were analyzed to evaluate the role of semaglutide therapy on all-cause, cardiovascular, and non-cardiovascular mortality during the COVID-19 pandemic.
PharmaVoice
SEPTEMBER 12, 2024
Eli Lilly’s head of ESG is maintaining a focus on sustainability even as the company’s expansion plans in weight loss drive a larger footprint and more social scrutiny.
STAT
SEPTEMBER 9, 2024
Going to the doctor is already tricky enough for people with chronic symptoms of Lyme disease. Their concerns often dismissed by mainstream medicine, those patients now face an additional hurdle: ruling out long Covid. The two illnesses — one seeping in over the course of decades and another suddenly springing to life on a massive scale — share many qualities, including being widely misunderstood.
Pharmacy Times
SEPTEMBER 12, 2024
Parents of children with cancer had the highest risk of developing mental illness and cardiovascular diseases.
Drug Topics
SEPTEMBER 10, 2024
The #MyCRChistory campaign encourages the public to share their family history of colorectal cancer.
Fierce Healthcare
SEPTEMBER 10, 2024
Half of women in the U.S. skip or delay medical care due to the “triple threat” of affordability, access challenges and past negative experiences, a new Deloitte report finds. | The Deloitte report, based on a survey of more than 2,000 consumers, found that 50% of women report skipping or delaying medical care and are 35% more likely to skip care than men.
STAT
SEPTEMBER 8, 2024
News that a person in Missouri contracted H5 bird flu despite having no known contact with infected animals or birds — in other words, no evident route of infection — raises pressing questions public health officials are surely scurrying to answer. The rationale for that urgency is this: An unexplained H5 infection raises the possibility of person-to-person spread of a flu virus that has never before circulated in humans, and to which people would not have immunity.
Pharmacy Times
SEPTEMBER 13, 2024
These results build off the PURPOSE 1 trial, contributing to the wealth of evidence surrounding lenacapavir’s positive effects in patients with HIV.
Drug Topics
SEPTEMBER 7, 2024
Check out a recap of important pharmacy news you might have missed this week, dispensed in small doses.
Expert insights. Personalized for you.
144 
Let's personalize your content